IPO Boutique

Argos Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Argos Therapeutics, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Argos TherapeuticsARGS -
NASDAQ
$13.00-$15.00 $8.00 $8.905.63 million2/7/2014
Piper Jaffray, Stifel, JMP Securities
Co-Manager(s):
Needham & Co.
Health Care
Filing(s):

Refiled 2013-12-30



Argos Therapeutics Quote & Chart - Click for current quote - ARGS

About Argos Therapeutics (adapted from Argos Therapeutics prospectus):
They are a biopharmaceutical company focused on the treatment of cancer and infectious diseases.

This description is adapted from Argos prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Argos "ARGS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved